Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | AMGN | BMY | VRTX | GILD |
| Company | Myovant Sciences Ltd | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 26.99 | 281.10 | 58.61 | 448.46 | 88.11 |
| High | 27.00 | 282.60 | 58.83 | 451.76 | 89.08 |
| Low | 26.98 | 278.56 | 57.84 | 445.38 | 87.77 |
| Last | 26.98 | 281.94 | 57.94 | 448.69 | 88.58 |
| Change | -0.01 | +1.99 | -0.29 | +0.68 | +0.83 |
| % Change | -0.04% | +0.71% | -0.50% | +0.15% | +0.95% |
| Volume | 2,256,000 | 1,737,168 | 2,121,415 | 605,085 | 1,071,186 |
| 20-Day Average Volume | 1,234,240 | 2,656,404 | 11,906,614 | 1,248,754 | 7,494,688 |
| Previous Close | 26.99 | 279.95 | 58.23 | 448.01 | 87.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 308.43 | 55.67 | 480.23 | 90.84 |
| 20-Day Raw Stochastic | 50.00% | 12.77% | 67.31% | 5.74% | 20.28% |
| 20-Day Relative Strength | 61.08% | 30.13% | 60.48% | 40.52% | 51.15% |
| Weighted Alpha | +96.20 | -1.75 | +25.52 | +17.80 | +23.98 |
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 96% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | -6.35% since 11/13/24 | -0.62% since 11/13/24 | -9.09% since 11/13/24 | -4.26% since 11/13/24 |
| Low | 26.95 on 03/06/23 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.38 on 11/20/24 | 86.08 on 11/19/24 |
| High | 27.00 on 03/09/23 | 298.48 on 11/14/24 | 59.73 on 11/14/24 | 496.33 on 11/14/24 | 92.66 on 11/14/24 |
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | -12.24% since 10/18/24 | +9.08% since 10/18/24 | -6.90% since 10/18/24 | +2.26% since 10/18/24 |
| Low | 26.90 on 02/13/23 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.38 on 11/20/24 | 85.60 on 10/22/24 |
| High | 27.06 on 02/13/23 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | -14.08% since 08/20/24 | +18.52% since 08/20/24 | -7.74% since 08/20/24 | +18.64% since 08/20/24 |
| Low | 26.75 on 12/16/22 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.38 on 11/20/24 | 74.80 on 08/21/24 |
| High | 27.06 on 02/13/23 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | -10.25% since 05/20/24 | +33.88% since 05/20/24 | +0.85% since 05/20/24 | +30.60% since 05/20/24 |
| Low | 16.26 on 09/23/22 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 27.06 on 02/13/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 150,482,384 | 118,100,752 | 115,375,568 | 109,359,840 |
| Shares Outstanding, K | 97,235 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 230,970,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -205,980,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 100,230,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -57,630,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 2.17 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 01/25/23 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.50 | 48.55 | 0.00 | 19.97 |